Key facts
- It has raised $4.4M across 1 recorded rounds; the latest was Seed Round ($2.8M) in Jan 2022.
- Notable investors include Asiarath, Fuel Accelerator, PioneerCrest Ventures.
- Ainnova Tech has filed 2 Form Ds with the SEC since 2022, most recently Aug 2025 ($2.8M sold to 21 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Ainnova Tech
Funding rounds
1 roundsAbout Ainnova Tech
Developer of an artificial intelligence-based technology designed for the early detection of diseases in an accessible and accurate way. The company's technology detects diabetic retinopathy and other diseases, such as cardiovascular risk, by retinal scans with high accuracy in seconds, enabling healthcare industry to get access to a technology that can detect diabetes in an early stage and hence prevent blindness or other serious conditions.
- Sector
- Healthcare
- HQ
- Houston, TX, United States
- Founded
- 2019
- Employees
- 10
- Website
- ainnovatech.com/
- Ownership
- Privately Held (backing)
Ainnova Tech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ainnova Tech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ainnova Tech in its N-PORT filings yet. We sweep new filings monthly.